Premium
P4–012: Allopregnanolone as a regenerative therapeutic for Alzheimer's disease, 1: From discovery to phase I multiple‐ascending‐dose clinical trial
Author(s) -
Brinton Roberta,
Irwin Ronald,
Mack Wendy,
Rodgers Kathleen,
Bauer Gerhard,
Rogawski Michael,
Schneider Lon
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1400
Subject(s) - medicine , clinical trial , allopregnanolone , neurogenesis , adverse effect , neural stem cell , neuroactive steroid , stem cell , pharmacology , oncology , neuroscience , biology , receptor , gabaa receptor , genetics